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Background: Poor sleep quality is known to precede the onset of mood episodes and to be associated with poor
treatment outcomes in bipolar disorder (BD). We sought to identify modifiable factors that correlate with poor
sleep quality in BD independent of residual mood symptoms.
Methods: A retrospective analysis was conducted to assess the association between the Pittsburgh Sleep Quality
Index and clinical variables of interest in euthymic patients with DSM-IV BD (n = 119) and healthy controls
(HC; n = 136) participating in the Prechter Longitudinal Study of Bipolar Disorder. Multivariable linear regression
models were constructed to investigate the relationship between sleep quality and demographic and clinical
variables in BD and HC participants. A unified model determined independent predictors of sleep quality.
Results and discussion: Euthymic participants with BD and HC differed in all domains. The best fitting unified
multivariable model of poor sleep quality in euthymic participants with BD included rapid cycling (β = .20, p = .03),
neuroticism (β = .28, p = 2 × 10−3), and stressful life events (β = .20, p = .02). Poor sleep quality often persists during
euthymia and can be a target for treatment. Clinicians should remain vigilant for treating subjective sleep
complaints independent of residual mood symptoms in those sensitive to poor sleep quality, including individuals
with high neuroticism, rapid cycling, and recent stressful life events. Modifiable factors associated with sleep quality
should be targeted directly with psychosocial or somatic treatment. Sleep quality may be a useful outcome
measure in BD treatment studies.
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Bipolar disorder (BD) is a prevalent and chronic psychiatric
disorder that is marked by significant impairment in cogni-
tive functioning and impaired quality of life, even during
euthymic well intervals (Merikangas et al. 2007; Pattanayak
et al. 2012; Ryan et al. 2012; Langenecker et al. 2010;
Marshall et al. 2012). For many people with BD, sleep is
persistently disrupted, and poor sleep quality is known to
precede the onset of both first and recurrent mood* Correspondence: esaunders@hmc.psu.edu
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in any medium, provided the original work is pepisodes (Gruber et al. 2011; Eidelman et al. 2010; Harvey
et al. 2005; Jones et al. 2005). In the general population,
disturbance of sleep is associated with poor functioning,
and insomnia with short sleep duration is associated with
poor cognitive functioning and risk for cardiovascular and
metabolic diseases (Bixler 2009; Fernandez-Mendoza et al.
2010a; Vgontzas et al. 2009a, b, c). Thus, some morbidity
and mortality associated with BD may be related to sleep
quality.
Sleep disturbances may be both a cause and a con-
sequence of BD (Talbot et al. 2012; Harvey 2008).
Evidence of alterations in the circadian rhythm sys-
tem comes from genetic and animal models of bi-
polar disorder (Benedetti et al. 2003, 2007; McClung
2007, 2011). Evidence-based somatic treatments (e.g.,is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Clinician-administered and self-report assessment
domains




DIGS (Nurnberger et al. 1994) Lifetime
Disease severity DIGS (Nurnberger et al. 1994) Lifetime
HDRS (Hamilton 1960) Past week




PSQI (Buysse et al. 1989) Past month
ESS (Johns 1991) None specified




NEO-PI-R (Costa and McCrae 1988) None specified
Life story/trauma CTQ (Bernstein et al. 1994) Lifetime
LEOS (McKee et al. 2005) Past six months
LEC (Johnson and McCutcheon 1980) Lifetime
FACES II (Olson et al. 1983) None specified
MRCIR (Vinokur and Vanryn 1993) None specified
Behavioral AUDIT (Saunders et al. 1993) Past year
FTND (Heatherton et al. 1991) None specified
DIGS Diagnostic Interview for Genetic Studies, HDRS Hamilton Depression
Rating Scale, YMRS Young Mania Rating Scale, PSQI Pittsburgh Sleep Quality
Index, ESS Epworth Sleepiness Scale, MCTQ Munich Chronotype Questionnaire,
NEO-PI-R NEO-Personality Index - Revised, CTQ Childhood Trauma
Questionnaire, LEOS Life Events Occurrence Survey, LEC Life Events Checklist,
FACES II Family Adaptability and Cohesion Evaluation Scale II, MRCIR Measures
Related to Close Interpersonal Relationships Support and Undermining Scale,
AUDIT Alcohol Use Disorders Identification Test, FTND Fagerstrom Test for
Nicotine Dependence.
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tive psychosocial treatments (e.g., interpersonal social
rhythm therapy, behavioral activation) for BD are
thought to exert their therapeutic effects, in part, by
directly or indirectly shifting, resetting, or stabilizing
systems associated with the sleep-wake cycle (Lamont
et al. 2007; Frank et al. 2005; McClung 2007).
Little is known about the determinants or correlates
of sleep quality during euthymic episodes in BD. In
epidemiologic studies of the general population, ad-
vancing age, menopausal status, high body mass index
(BMI), medical comorbidities, anxiety disorders, stress,
and nicotine and substance use are associated with sleep
quality (Bixler 2009). In addition, stress and personality
factors may play a role in determining sleep quality
(Healey et al. 1981; LeBlanc et al. 2007; Marks and
Roffwarg 1991; Singareddy et al. 2012; Fernandez-
Mendoza et al. 2012a). These factors - aside from
advancing age and menopausal status - are generally
overrepresented in the BD population (Saunders et al.
2008, 2012; Fagiolini et al. 2002; Swartz and Fagiolini
2012; Prochaska et al. 2011; Dickerson et al. 2013)
and thus may be determinants or correlates of sleep
quality in the BD population. Against this backdrop,
we used data from the baseline visit of the Prechter
Longitudinal Study of Bipolar Disorder to understand
the effect of clinical features, personality traits, and
life events on self-reported sleep quality in a sample
of BD subjects who were euthymic and a sample of
healthy control (HC) subjects. The Prechter Longi-
tudinal Study is a naturalistic, observational study
designed to link detailed clinical assessment of psy-
chiatric and medical history, as well as sleep, stress,
environmental factors, substance use, personality, and
cognition, to clinical outcomes and genetic and biological
data for patients being treated with usual clinical care. We
hypothesized that factors in the domains of medical,
substance use disorder, and anxiety disorder comor-
bidities; dimensional/personality traits; life story/trauma;
and behavioral domain would show associations with
sleep quality in the BD and HC samples similar to those
in the general population, and we hypothesized that
features of illness in the BD group such as history of
suicide attempts, psychosis, mixed episodes, rapid cycling,
and high number of episodes would be related to sleep
quality.
Our interest in correlates of sleep quality during
euthymic episodes in BD is driven by the following
questions: Are there modifiable factors that can reli-
ably predict sleep quality and be targeted for treat-
ment, thus reducing the morbidity and mortality
associated with poor sleep quality in BD? Can sleep
quality be a useful outcome measure in BD treatment
studies?Methods
Participants
Patients with BD (i.e., bipolar disorder type I, bipolar
disorder type II, schizoaffective disorder, bipolar type or
bipolar disorder NOS, Table 1) and HCs with no per-
sonal or family history of mood or psychotic disorders
were recruited to the Prechter Longitudinal Study of
Bipolar Disorder at the University of Michigan, an IRB-
approved observational study of outcomes in bipolar
disorder (IRBMED HUM000606). Participants in the
Prechter Longitudinal Study were seen for a baseline
assessment described below and followed long-term with
self-reported questionnaires and yearly visits.
Analytic cohort
The clinical sample for this investigation included parti-
cipants recruited at the University of Michigan between
2005 and 2010, and data were extracted in February
2012. The cohort selected for analysis included euthymic
patients with BD (n = 119) and HCs (n = 136) who com-
pleted the Pittsburgh Sleep Quality Inventory (PSQI) at
baseline. Participants were excluded in the current
analysis if they did not have complete data on the PSQI
Table 2 Sociodemographic characteristics and diagnosis
of the sample
HC BD p value
(n = 136) (n = 119)
Female, n (%) 76 (56) 79 (66) .09
Menopausal, n (%) 9 (13) 20 (28) .02
Age, mean (SD) 32.4 (13.7) 40.5 (12.8) <1 × 10−3
Age, range 18 to 66 19 to 65
BMI, mean (SD) 25.6 (5.8) 28.9 (6.9) <1 × 10−3
Married, n (%) 35 (26) 52 (44) 3 × 10−3
Employed/student, n (%) 107 (84) 78 (70) 7 × 10−3
Bipolar I disorder, n (%) 90 (76)
Bipolar II disorder, n (%) 17 (14)
Bipolar NOS, n (%) 10 (8)
Schizoaffective (BP type), n (%) 2 (2)
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Rating Scale (HDRS) ≥7, n = 99) or manic/hypomanic/
mixed symptoms (Young Mania Rating Scale (YMRS) ≥7,
n = 35).
At baseline, clinicians administered the Diagnostic
Interview for Genetic Studies (DIGS) (28), HDRS (29),
and YMRS (3), and recorded height and weight. The
DIGS is a clinician-administered diagnostic interview
that includes comprehensive assessment of psychiatric
and medical illnesses and includes the ability to assess
the lifetime course of mood disorder as well as asso-
ciated features of mood illness of the individual.
Interviewers included physicians, psychologists, and
masters-level mental health professionals who completed
standardized training in the study instruments, and a
best-estimate procedure was used to verify diagnoses
(Leckman et al. 1982). Participants completed a baseline
set of self-rating questionnaires. Data from the clinical
interview and questionnaires were used to assess
domains of interest that may relate to sleep quality
including sociodemographic factors; clinical features/
comorbidities; disease severity; chronotype, sleep, and
sleepiness; dimensional/personality traits; life story/
trauma history; and behavioral features including sub-
stance use (Table 1). Our dependent variable of interest
was sleep quality, assessed with the PSQI (Buysse et al.
1989). The PSQI obtains a general measure of sleep
quality, and the total score is derived from seven sub-
scales: sleep quality, sleep latency, sleep duration, sleep
efficiency, sleep disturbance, sleep medication, and day-
time dysfunction. Comparisons of the PSQI subscales
were reported between HC and BD groups, and the total
PSQI score is used as a dependent variable in analyses.
Chronotype was assessed with the Munich Chronotype
Questionnaire (MCTQ) (Roenneberg et al. 2003), which
assesses preference for sleep and wake times.
Data and statistical analysis
Values of continuous variables were compared between
BD and HC groups using two-sample t tests for nor-
mally distributed variables or Mann–Whitney U tests for
variables with a skewed distribution. Categorical vari-
ables were compared using Pearson's chi-square test.
Linear regression models were constructed for each con-
tinuous variable and logistic regression models for each
categorical variable to investigate the difference between
groups while adjusting for age, sex, and BMI.
Sleep quality (total PSQI score) was correlated with
demographic and clinical variables in each of the HC
and BD groups first through the use of bivariate
comparisons with Pearson's r for normally distributed
variables or Spearman's r for variables that were not nor-
mally distributed. To determine independent correlates
of poor sleep quality, variables correlated in bivariatecomparisons were included in a series of multivariable
linear regression models organized by the following
domains: sociodemographic factors; clinical features/
comorbidities; disease severity; chronotype, sleep, and
sleepiness; dimensional/personality traits; life story/
trauma history; and behavioral features. Anxiety dis-
order comorbidity included obsessive-compulsive dis-
order, panic disorder with or without agoraphobia,
social phobia, specific phobia, and agoraphobia with-
out panic. Post-traumatic stress disorder was not
included because we did not have a systematic assess-
ment of this disorder. All models at the domain level
were adjusted for current depressive symptoms. Final
models in each domain were chosen through a backward
selection process. Correlates that were independently
associated in the domain-wide analyses were selected for a
unified multivariable model that was chosen through
backward selection.Results
Demographic description of the sample
The average subject with BD (n = 119) was a 41-year-
old, married (44%), employed (70%) female (66%) with a
BMI of 29 (Table 2). The average HC (n = 136) was a 32-
year-old, not married (74%), employed (84%) female
(56%) with a BMI of 25 (Table 2). The age range of the
two groups was similar (BD 19 to 65, HC 18 to 66).
Approximately one sixth of the HC females had under-
gone menopause, whereas the rate was one quarter in
the BD females. The BD group had significantly more
females who were menopausal, had a significantly older
group, and a higher BMI. Significantly more BD indi-
viduals were married, and significantly more HC were
employed or students (Table 2).
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Differences in clinical characteristics between HC and
BD subjects are summarized in Table 3, both unadjusted
and adjusted for age, sex, and BMI (p values reported
below are adjusted unless noted otherwise). BD subjects
had higher rates of migraine headaches than HC (p =
5 × 10−3), but not cardiovascular disease (p = .08) or
diabetes (p = .25) after adjusting for age, sex, BMI, and
marital and employment/student status. Rates of past
history of alcohol use disorders, past history of drug use
disorders, and lifetime anxiety disorders (obsessive-com-
pulsive disorder, panic disorder with or without ago-
raphobia, social phobia, specific phobia, agoraphobia
without panic) were 36%, 17%, and 20%, respectively, in
the BD group. BD subjects reported a lifetime history of
rapid cycling (29%), suicide attempts (33%), and psych-
osis (59%). A history of mixed episodes, defined by the
DSM-IV-TR definition of concurrent manic and depres-
sive episode at the same time, was present in 23% of the
sample, and that of mixed symptoms, defined as the
presence of subsyndromal manic symptoms during de-
pression or subsyndromal depressive symptoms during
mania, was present in 36% of the sample. The average
age at onset of BD was 19.2 ± 8.3. The number of epi-
sodes was highly skewed to the right, and the BD sample
had a median of 5 depressive episodes, 2 manic episodes,
and 3 hypomanic episodes. Even in this euthymic sam-
ple, current depressive and manic symptoms were higher
in the BD than in the HC group (p < 1 × 10−3).
BD subjects had poorer sleep quality relative to HC
subjects as measured by the PSQI total score as well as
the subscales of sleep quality, sleep latency, sleep
disturbance, sleep medication, and daytime dysfunction
due to sleepiness (p < .01). Two of the scales did not dif-
fer, including sleep duration (p = .19) and sleep efficiency
(p = .42). Sleepiness was also elevated in the BD group as
measured by the Epworth Sleepiness Scale (ESS; p = .01).
Chronotype did not differ between the BD and HC
groups (p = .40).
Five-factor personality traits that differed in the BD
group included elevated neuroticism and openness and
lower conscientiousness (p < 7 × 10−3). The BD group
had higher levels of childhood trauma (p < 1 × 10−3). The
BD group reported higher levels of undesirable events in
the last 6 months (p = 3 × 10−3), but the total number of
stressful life events did not differ between BD subjects
and HCs (p = .74). Family cohesion was lower in the BD
group (p < 1 × 10−3), and family adaptability was lower as
well (p = .03). Social support was significantly lower in the
unadjusted pairwise comparison (unadjusted p = 4 × 10−3);
however, no difference was detected when adjusted for
age, sex, BMI, and marital and employment/student status
(p = .12). Social undermining was higher in the BD group
(p = 2 × 10−3). Current use of alcohol did not differbetween groups (unadjusted p = .28); however, current use
of drugs and nicotine was higher in BD (unadjusted
p < .04).
Correlates of sleep quality in HC subjects
Sleep quality was correlated with demographic and clin-
ical variables in the HC group first through the use of
Pearson's r. Variables that were significantly correlated
with poor sleep quality included being married (r = .28,
p = 1 × 10−3) and Measures Related to Close Interper-
sonal Relationships (MRCIR) Undermining Scale (r = .25,
p = 3 × 10−3). There was a trend for association with
neuroticism (r = .16, p = .07) and current depressive
symptoms (HDRS 21 with atypical, r = .17, p = .05). Age
(r = .12, p = .18) and female gender (r = −.11, p = .90)
were not associated with sleep quality in HC. To deter-
mine independent correlates of sleep quality, variables
that were correlated in bivariate comparisons were then
included in a series of multivariable linear regression
models. The final model was chosen through a back-
ward selection process. MRCIR social undermining
was determined to be an independent predictor of
sleep quality (Β = .20, p = .02) when controlled for marital
status and current depressive symptoms (F = 6.74, df = 3,
p < 1 × 10−3; adjusted R2 = .12).
Correlates of sleep quality in euthymic BD subjects
To determine independent predictors of sleep quality in
a euthymic BD sample, clinical variables of interest were
first tested with sleep quality in bivariate correlations.
Significant correlates at the bivariate level were included
in multivariable regression models by domain, and then
a unified multivariable model was created that included
all significant correlates from the models by domain
(Table 4). In the models by domain, current depressive
symptoms were significantly associated with poor sleep
quality in each model except personality features.
Current depressive symptoms dropped out of the final
unified model.
In the final unified model, independent correlates of
sleep quality in the BD group included rapid cycling
(β = .20, p = .03), undesirable events (β = .20, p = .02), and
neuroticism (β = .28, p = 2 × 10−3) (Table 4, Figure 1). Of
the features of illness, suicide attempts were the most
strongly correlated with sleep quality in the bivariate
correlations, and remained significant in the model
within the features of illness domain, but dropped out of
the unified model. Mixed episodes were also significant
in the bivariate correlations, but not in either the
features of illness domain model or the unified model.
Suicide attempts and rapid cycling were correlated with
each other (r = .31, p = 1 × 10−3), and suicide attempts
and mixed episodes were correlated with each other
(r = .32, p = 1 × 10−3); however, rapid cycling and mixed
Table 3 Clinical characteristics of the sample
Clinical characteristic by domain HC BD p valuea p value
adjustedb(n = 136) (n = 119)
Medical, substance use disorder, and anxiety disorder comorbidities, n (%)
Cardiovascular disease 8 (6) 24 (21) 1 × 10−3 .08
Diabetes 2 (2) 11 (9) 5 × 10−3 .25
Migraine 9 (7) 27 (23) <1 × 10−3 5 × 10−3
Alcohol use disorders - 43 (36) - -
Drug use disorders - 20 (17) - -
Anxiety disorder - 24 (20) - -
Features of BD, n (%)
Mixed episodes - 25 (23) - -
Rapid cycling - 34 (29) - -
Suicide attempts - 39 (33) - -
Mixed symptoms - 38 (36) - -
Psychosis - 68 (59) - -
Severity/symptom measures, mean (SD)
Age at onset (years) - 19.2 (8.3) - -
Depression (number of episodes) - 5 (8) - -
Mania (number of episodes) - 2 (3) - -
Hypomania (number of episodes) - 3 (20) - -
Current symptom state
HDRS 17 0.57 (1.32) 2.06 (1.99) <1 × 10−3 <1 × 10−3
HDRS 21 with atypical symptoms 0.76 (1.61) 3.93 (4.39) <1 × 10−3 <1 × 10−3
YMRS 0.13 (0.63) 1.21 (1.84) <1 × 10−3 <1 × 10−3
Chronotype, sleep, and sleepiness, mean (SD)
PSQI total score 3.82 (2.7) 6.45 (3.41) <1 × 10−3 <1 × 10−3
Sleep quality 0.37 (0.53) 1.03 (1.00) <1 × 10−3 <1 × 10−3
Sleep latency 0.74 (0.75) 1.08 (0.98) 3 × 10−3 .01
Sleep duration 1.00 (1.09) 0.84 (1.07) .24 .19
Sleep efficiency 0.30 (0.72) 0.43 (0.79) .18 .42
Sleep disturbance 0.50 (0.74) 1.13 (1.02) <1 × 10−3 <1 × 10−3
Sleep medication 0.70 (0.59) 0.99 (0.73) <1 × 10−3 4 × 10−3
Daytime dysfunction 0.21 (0.46) 0.94 (0.91) <1 × 10−3 <1 × 10−3
ESS sleepiness 5.38 (3.27) 6.58 (4.18) .01 .01
MCTQ 3.20 (1.63) 3.03 (1.90) .46 .40
Dimensional/personality traits, mean (SD)
NEO-PI neuroticism 44.99 (9.18) 58.38 (13.24) <1 × 10−3 <1 × 10−3
NEO-PI extraversion 52.78 (8.63) 50.26 (10.55) .04 .49
NEO-PI openness 56.59 (10.71) 59.26 (12.07) .06 7 × 10−3
NEO-PI agreeableness 49.75 (10.68) 50.44 (12.51) .63 .81
NEO-PI conscientiousness 49.20 (10.61) 43.58 (13.27) <1 × 10−3 1 × 10−3
Life story/trauma, mean (SD)
CTQ childhood trauma 34.27 (8.11) 46.60 (17.34) <1 × 10−3 <1 × 10−3
LEOS undesirable events 0.85 (1.43) 1.63 (2.17) 1 × 10−3 3 × 10−3
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Table 3 Clinical characteristics of the sample (Continued)
LEC stressful life events 4.90 (3.77) 4.56 (3.31) .44 .74
FACES-II cohesion 62.02 (9.39) 55.67 (13.79) <1 × 10−3 <1 × 10−3
FACES-II adaptability 46.63 (7.75) 43.54 (10.85) .01 .03
MRCIR social support 42.70 (6.82) 39.78 (8.90) <4 × 10−3 .12
MRCIR undermining 11.02 (3.64) 13.07 (4.96) <1 × 10−3 2 × 10−3
Behavioral, median (IQR)
Current use
AUDIT alcoholc 0 (4) 3 (5) .28
AUDIT drugsc 0 (0) 0 (0) .02
FTND nicotine dependencec 0 (0) 0 (0) .04
DIGS Diagnostic Interview for Genetic Studies, HDRS Hamilton Depression Rating Scale, YMRS Young Mania Rating Scale, PSQI Pittsburgh Sleep Quality Index,
ESS Epworth Sleepiness Scale, MCTQ Munich Chronotype Questionnaire, NEO-PI-R NEO-Personality Index - Revised, CTQ Childhood Trauma Questionnaire, LEOS Life
Events Occurrence Survey, LEC Life Events Checklist, FACES II Family Adaptability and Cohesion Evaluation Scale II, MRCIR Measures Related to Close Interpersonal
Relationships Support and Undermining Scale, AUDIT Alcohol Use Disorders Identification Test, FTND Fagerstrom Test for Nicotine Dependence. ap values from
comparisons of continuous variables made using independent t tests except for AUDIT alcohol, AUDIT drugs, and FTND nicotine dependence, and p values from
comparisons of categorical variables made using chi-square tests; bp values from linear regressions including the score of the scale of interest as a dependent
variable, with age, sex, BMI, employment/student status, marital status, and euthymic BD/HC group as independent variables; ccomparisons between HC and BD
are made with Mann–Whitney U tests.
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story realm, Life Events Occurrence Survey (LEOS)
undesirable events was the strongest correlate in the
model by life story domain and remained significant in the
unified analysis. Neuroticism was the strongest correlate
in the personality assessment domain and in the unified
analysis as well.
The only sociodemographic factor that was significant
was marital status, but it did not enter into the final
model after adjusting for other significant correlates.
Cardiovascular (p = .08) and drug use disorders (p = .07)
were marginally associated with poor sleep quality in the
comorbidity domain. In the severity of illness domain, age
at onset of BD was significant in the bivariate correlations,
and at the domain level, but dropped out of the unified
model. Chronotype was also significant at the domain
level, but was not present in the unified model.
Discussion
In this study of euthymic patients with BD, correlates of
poor sleep quality independent from residual depressive
symptoms were examined in multiple domains that
might be expected to affect sleep quality, including
sociodemographic factors, medical and anxiety disorder
comorbidities, features of BD, severity/symptom mea-
sures, chronotype and sleepiness, personality, life story/
trauma, and behavioral factors. When domain-wide pre-
dictors were included in a final model, independent
predictors of poor sleep quality in the BD sample in-
cluded rapid cycling, high neuroticism, and undesirable
events in the past 6 months, and those in the HC sample
included social stress.
We can conceptualize poor sleep quality during
euthymia in five ways: (1) as a causative trigger for anew mood episode, (2) as a prodromal sign or early
symptom of a new mood episode, (3) as a residual symp-
tom of a remitted mood episode, (4) as a distinguishing
characteristic of a bipolar phenotype, and (5) as a
comorbid sleep disorder/condition. By restricting the
analysis to patients in a euthymic period, we designed
our approach to study sleep quality as a characteristic of
bipolar disorder. Though these subjects were in a tra-
ditionally defined ‘euthymic’ period, there was a range of
subsyndromal symptoms in this population, consistent
with a number of other studies indicating that sub-
syndromal depressive symptoms are common and
predict recurrence (Perlis et al. 2006). The prevalence of
subsyndromal symptoms such as poor sleep quality has
led some groups to refer to periods without major mood
episodes as ‘interepisode’ rather than euthymia (Harvey
2008). In our study, poor sleep quality was correlated
with subsyndromal depressive symptoms in euthymic
participants when not adjusted for other factors. How-
ever, when depressive symptoms were included with
other factors affecting sleep quality, the correlation with
depressive symptoms was lost, indicating that we found
factors that affect sleep quality independently of sub-
syndromal symptoms. We continue to describe the
cohort as euthymic to remain consistent with the bulk
of the literature; however, the term interepisode should
be considered. Whether poor sleep quality in this
population is best categorized as prodromal or residual,
treatment targeting the sleep quality outside of targeting
depressive symptoms may reduce the substantial im-
pairment and disruption in social and occupational
functioning.
We found some consistencies between factors as-
sociated with poor sleep quality and psychological and
Table 4 Correlates of poor sleep quality in euthymic bipolar subjects (n = 119)
Domain Bivariate Multivariable regression modelsa Unified multivariable regression modelb
r β (p) β (p)
Sociodemographic Adjusted R2 = .09 Adjusted R2 = .20
Married −.23 (.01) −.21 (.02) -
Age 4 × 10−3 - -
Menopausal status (F) .01 - -
Sex .04 - -
Employed −.13 - -
Medical and anxiety disorder comorbidities Adjusted R2 = .11
Cardiovascular disease .20 (.03) .16 (.08) -
BMI .17 (.07) - -
Diabetes .05 - -
Migraine .13 - -
Alcohol use disorders .16 (.08) - -
Drug use disorders .17 (.07) .17 (.07) -
Anxiety disorder −.09 - -
Features of BD Adjusted R2 = .15
Suicide attempts .31 (1 × 10−3) .22 (.02) -
Rapid cycling .30 (1 × 10−3) .20 (.04) .20 (.03)
Mixed episodes .20 (.04) - -
Mixed symptoms .13 - -
Psychosis .11 - -
Severity/symptom measures Adjusted R2 = .06
Age at onset −.20 (.03) −.18 (.07) -
Depression (number of episodes) .33 (<1 × 10−3) - -
Mania (number of episodes) .16 (.09) - -
Hypomania (number of episodes) .23 (.01) - -
Current symptom state
HDRS 17 .11 - -
HDRS 21 with atypical symptoms .24 (.01) - -
YMRS −.01 - -
Chronotype and sleepiness Adjusted R2 = .10
MCTQ chronotype .24 (.01) .23 (.01) -
ESS sleepiness .16 (.08) - -
Personality assessment Adjusted R2 = .13
NEO-PI neuroticism .35 (<1 × 10−3) .31 (1 × 10−3) .28 (2 × 10−3)
NEO-PI extraversion −.01 - -
NEO-PI openness .06 - -
NEO-PI agreeableness −.01 - -
NEO-PI conscientiousness −.17 (.08) - -
Life story Adjusted R2 = .11
LEOS undesirable events .26 (.01) .27 (.01) .20 (.02)
CTQ childhood trauma .19 (.04) - -
LEC stressful life events .09 - -
FACES-II cohesion −.20 (.03) - -
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Table 4 Correlates of poor sleep quality in euthymic bipolar subjects (n = 119) (Continued)
FACES-II adaptability −.15 - -
MRCIR social support −.20 (.03) - -
MRCIR undermining .10 - -
Behavioral
AUDIT alcohol −.07 - -
AUDIT drugs −.10 - -
FTND nicotine dependence .13 - -
aSet of predictors in a series of linear regressions with backward selection in each domain after adjusting for depressive symptoms (β ranges from .17 to .26,
p < .07); bmultivariable linear regression, final model obtained through backward selection.
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sleep quality in the general population. In the HC group,
social undermining predicted poor sleep, whereas in the
BD group, association was found between poor sleep
and neuroticism and stressful life events. Neuroticism is
measured in the widely used five-factor model of
personality developed by Costa and McCrae, which also
measures extraversion (E), openness (O), agreeableness
(A), and conscientiousness (C) (Costa and McCrae
1992). Neuroticism (N) measures the tendency to expe-
rience negative affects including fear, sadness, embar-
rassment, anger, and disgust. Individuals with BD have
been shown to have elevated N and O, and low A, C,
and E (Barnett et al. 2011). N marks a trait that has been
associated with many psychiatric illnesses in addition to
BD, including major depressive disorder, anxiety disor-
ders, and personality disorders (Barnett et al. 2011;
Costa et al. 2005; Middeldorp et al. 2011; Bagby et al.
2008; Bienvenu et al. 2004). Personality traits have high
heritability and may predispose individuals to psychiatric
illness; however, there is some indication that personality
traits may be affected by psychiatric illness as well
(Costa et al. 2005; Christensen and Kessing 2006). We
believe that the association between poor sleep qualityFigure 1 Independent risk factors for poor sleep quality in euthymicand neuroticism reported here is a general phenomenon
which may be enhanced and exaggerated in BD patients,
perhaps due to genetic predisposition, but is not unique
to BD or to psychiatrically ill populations.
We found that poor sleep quality was associated with
stressful events in euthymic BD and social stress in the
HC group, which has also been found in general popula-
tion samples (Fernandez-Mendoza et al. 2010b; LeBlanc
et al. 2007). This is particularly important for BD because
social stress has been shown to be greater in BD patients
even when euthymic and was shown to be bi-directionally
related to disturbed sleep (Eidelman et al. 2012). Affect
reactivity in response to stress has also been shown to be
greater in euthymic BD than in unipolar depressive
disorder or controls (Knowles et al. 2007). Negative mood
and sleep have also been shown to have a bi-directional
relationship in a euthymic bipolar population; that is,
negative mood in the evening may disturb sleep, and
disturbed sleep may cause negative mood in the morning
(Talbot et al. 2012). Close attention to the role of stress
and mood reactivity is warranted in future studies of sleep
quality in euthymic BD.
A history of rapid cycling was related to poor sleep
quality in the euthymic BD group. Rapid cycling may bebipolar disorder.
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short euthymic periods between episodes, and similar to
stress reactivity, rapid cycling can be conceptualized as
both a cause of poor sleep quality and a result of un-
derlying poor sleep quality. In fact, rapid cycling may
describe a distinct phenotype with biologically different
properties driving both the mood and sleep disturbance.
For example, rapid cycling has been linked to panic dis-
order in familial and genetic studies (MacKinnon and
Zamoiski 2006; MacKinnon et al. 2003a, b) and has also
been linked to low-activity risk alleles of the catechol-O-
methyl transferase gene (Papolos et al. 1998; Kirov et al.
1998; Joyce et al. 1995) as well as abnormalities in the
hypothalamic-pituitary-thyroid axis (Chakrabarti 2011).
In addition, the hypothalamic-pituitary-adrenal (HPA)
axis is an important modulator of sleep and the immune
system and is abnormally activated in chronic insomnia
(Vgontzas and Chrousos 2002; Vgontzas et al. 2004,
2007; Basta et al. 2007). One pilot study has shown
abnormally high cortisol and high cortisol response to
the dexamethasone suppression test in five patients with
rapid cycling, regardless of mood state (Watson et al.
2005). Underlying HPA axis dysfunction at baseline or in
response to stress may link sleep quality, rapid cycling,
and stress reactivity in BD. Rapid cycling is associated
with the severity of BD illness and poor outcome
(Schneck et al. 2004), and as has been shown in other
studies, both rapid cycling and mixed episodes were
highly correlated with suicide attempts (Coryell et al.
2003). In this sample, though both rapid cycling and
mixed episodes were associated with suicide attempts,
rapid cycling and mixed episodes were distinct from
each other.
We did not find medical comorbidities, smoking, alco-
hol or drug use, or anxiety disorders to be significantly
associated with sleep quality in HC or BD, when adjus-
ting for other contributing factors. However, we had very
few participants who reported active substance use, in
part because active substance dependence was an ex-
clusion criterion of the study. In our sample, HCs were
younger and had a very low rate of CV disease. Cardio-
vascular disease and obesity have been associated with
insomnia and overall poor sleep quality (Vgontzas et al.
2009a, b, c). In the BD sample, we found a significant
association between sleep quality and cardiovascular
disease in bivariate correlations and a trend toward asso-
ciation with obesity, but neither was significant in the
final model. The domain-wide model identified cardio-
vascular disease as a stronger predictor of poor sleep
quality than obesity.
Diagnosis of anxiety disorder did not affect sleep qual-
ity in the BD sample. Though this appears contradictory
to the literature showing anxiety affects sleep quality
(Fernandez-Mendoza et al. 2012a; Singareddy et al. 2012;Fernandez-Mendoza et al. 2012b), several factors may
account for this lack of association. First, anxiety disorder
comorbidity was half as common in this sample as other
samples that were not restricted to euthymic patients, and
in the Prechter cohort, if baseline mood is not restricted
to euthymia, rates of anxiety disorders are very similar to
published reports (Otto et al. 2006; Saunders et al. 2012).
Because anxiety disorders are associated with worse
course and severity of illness in BD (Goes et al. 2011;
McLean et al. 2011; Saunders et al. 2012), they were un-
derrepresented in our sample, which was restricted to
euthymia. Two additional factors include the following:
we did not have a systematic assessment of post-traumatic
stress disorder (PTSD) included in anxiety disorders on all
of our subjects, and we did not have a measurement of
general anxiety outside of the specific anxiety disorders
noted above. Future study of a measure of general
anxiety may elucidate the relationship between anxiety
and sleep in BD.
Though we did not have a measure of PTSD for all
participants, we did examine the relationship between
childhood trauma (CTQ), adult trauma (LEC), and poor
sleep. Childhood trauma, but not adult trauma, was
higher in the BD group, and associated with sleep quality
in bivariate analysis, but recent undesirable events
(LEOS) were a stronger predictor of poor sleep quality
than childhood trauma in this sample. Recent stresses
may have a stronger effect on sleep than childhood trau-
matic events due to the proximal temporal relationship.
An alternate explanation is that individuals with BD who
have recurring difficulties from trauma are continuing to
have persistent depressive symptoms and may not be
represented in this sample.
In the life story/trauma domain, raw scores for social
support were lower in the BD group than in the HC
group, but this difference was not significant after
adjustment for age, sex, BMI, and marital and em-
ployment/student status; however, social undermining
remained significantly higher in the BD group than in
the HC group. This could be due to several reasons -
the HC group is much younger, which was likely the
reason for fewer marriages in this group. Thus, the BD
group may have more individuals who are married, but
fewer are employed or students, and may have a res-
tricted social circle, and the marriage may not be a
supportive one, but more of the HC are students with a
social network.
We expected to find significant differences in sleep
quality between women who had undergone menopause
and those who have not, as previous population-based
studies have shown (Chung and Tang 2006; Blumel
et al. 2012; Monterrosa-Castro et al. 2012). One ex-
planation is that the influence of BD on sleep quality
may be more important than the effect of menopause;
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pre- and post-menopause. However, in this study, we
had only self-reports of menopause, which may mean
that peri-menopausal women are included in the pre-
menopausal sample.
Limitations of this study include the subjective and
retrospective nature of the PSQI. The PSQI measures an
aggregate of sleep quality that includes many dimensions
that are influenced by many factors, including the use of
medications to promote sleep (Buysse et al. 1989). The
use of medication may affect the presentation of BD,
and thus, it is important to ask how the use of medica-
tion may have affected the variables examined in this
study. Rapid cycling has been linked to antidepressant
use in some studies (Fountoulakis et al. 2013); however,
in this sample of euthymic BD subjects, antidepressants
were used by a quarter of the participants (n = 31) at
baseline, and the use was not correlated to the PSQI
score (r = .03, p = .76), neuroticism (r = .08, p = .40),
rapid cycling (r = .07, p = .46), or stressful events (r = .01,
p = .95). An additional limitation includes the lack of
objective physiological measures of physical health other
than BMI. The contribution of cardiovascular or phy-
siological measures that may contribute to poor sleep
quality is likely underestimated in this study. In addition,
our control group was younger than the BD group. How-
ever, we adjusted for age when comparing the HC and BD
groups. The study strengths include a large sample of
patients with well-characterized BD, as well as dimen-
sional measures of sleep, personality, psychosocial stress,
and behavioral measures.
Conclusions
Poor sleep quality is associated with depressive and
manic episodes but often persists between episodes.
Treatment of poor sleep quality between episodes is a
frequent clinical problem, and targets for improving
sleep quality, in addition to targeting residual mood
symptoms, may improve outcomes in BD. Here, we
present correlates of poor sleep quality that may be used
to target treatments. Clinicians should remain vigilant
for treating subjective sleep complaints independent of
mood complaints in BD patients sensitive to poor sleep
quality, including individuals with high neuroticism and
rapid cycling. Reactivity to stressful life events during
euthymia can be a target for psychotherapy, and mo-
dification may improve stress response. Association
between poor sleep quality and rapid cycling emphasizes
the importance of treatment of frequently cycling moods
and improving sleep quality as mood and sleep quality
each impact each other. BD patients with recent life
stressors, history of rapid cycling, and high neuroticism
are at elevated risk of experiencing poor sleep quality.
Areas for further study include identifying correlates ofspecific subjective sleep complaints and using a home-
based objective sleep measure such as actigraphy to
describe sleep-related risk factors for poor outcome in
BD (Faurholt-Jepsen et al. 2012; Kaplan et al. 2012; Jones
et al. 2005).
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